A Message from the Chair
Close your eyes. Imagine losing your sight. Now open them and imagine the sheer joy of getting it back. At Stanford Medicine, we're privileged to give this joy to many of our patients. But for those with the worst degenerative eye diseases, there are still very few options.
Too many of us live in fear of losing our sight, and with it, our independence. We're facing an epidemic of blindness as America ages. And if we don't act, the number of us afflicted with diseases like age-related macular degeneration and glaucoma will double by 2050.
Our vision is to prevent this from happening with a comprehensive multidisciplinary research endeavor. Recent breakthroughs in neuroscience, genetics, imaging, stem cell medicine, and technology have given us a real shot at curing these as-yet incurable diseases and reversing the vision loss they cause.
Stanford's unmatched depth and breadth of expertise in each of these fields is the reason I came here. It's also why my friend and benefactor Mary Spencer established the Mary M. and Sash A. Spencer Center for Vision Research here at the Byers Eye Institute. No other place can leverage all these breakthroughs to find new cures. But finding cures isn't enough. We must get them to patients faster. So, we're developing new ways to monitor and even manufacture new therapies to accelerate clinical trials.
From discovery to delivery, we'll bring together the best minds and the best technologies to end blindness no matter what the cause. Please help Mary and I give everyone the joy of sight.
Jeffrey Goldberg, MD, PhD
Chairman and Professor of Ophthalmology
Read our brochure to learn how philanthropy fuels our vision to find new treatments and cures for blindness.